Who has invested in Hongyun Biotech?

Lotus Lake Capital Management are named among the investors backing Hongyun Biotech.

Hongyun Biotech Funding: $16M Raised, Series B (2023)

Hongyun Biotech funding overview

Hongyun Biotech is based in Nanjing, China. Hongyun Biotech has raised $16M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Series B announced in May 2023. The round record for Hongyun Biotech runs through 2023; nothing later has been disclosed. Investors on record include Lotus Lake Capital Management.

Hongyun Biotech at a glance

Total raised: $16M
Latest round: Series B
Latest round date: May 2023
Headquarters: Nanjing, China
Notable investors: Lotus Lake Capital Management

Frequently asked about Hongyun Biotech funding

How much has Hongyun Biotech raised?: Hongyun Biotech has raised $16M in total disclosed funding across the rounds on record.
Who has invested in Hongyun Biotech?: Lotus Lake Capital Management are named among the investors backing Hongyun Biotech.
What was the latest Hongyun Biotech funding round?: The most recent disclosed round is a Series B, announced in May 2023.
Where is Hongyun Biotech based?: Hongyun Biotech is based in Nanjing, China.
When did Hongyun Biotech last raise?: The last disclosed Hongyun Biotech round closed in May 2023 at Series B.

Hongyun Biotech totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Nanjing below to benchmark round size and investor mix.

Hongyun Biotech Funding: $16M Raised, Series B (2023)

Hongyun Biotech funding overview

Hongyun Biotech at a glance

Frequently asked about Hongyun Biotech funding

Companies related to Hongyun Biotech (19)

Browse related funding lists (3)